摘要
目的提高危重症感染性疾病的诊断及救治水平,规范纳米孔测序的临床应用,促进该技术的良性发展。方法由中国药理学会治疗药物监测研究专业基层委员会和广东省药学会临床治疗精准用药专家委员会发起并组织多学科专家,采用名义群体法讨论确定共识编写大纲,形成共识初稿;采用德尔菲法进行专家咨询,对专家意见进行分析和修订,形成共识。结果与结论最终制定的《纳米孔测序在病原微生物检测中的应用专家共识》涵盖了靶向测序、宏基因组测序和全基因组测序等方向,对纳米孔测序的样本采集与保存、检测过程、生物信息学分析、报告解读等全流程进行了规范,并对其中的关键问题给出了推荐意见。
OBJECTIVE To improve the diagnosis and treatment level of critically ill infectious diseases,standardize the clinical application of nanopore sequencing and promote the sound development of the technology.METHODS Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society and Expert Committee of Precision Medicine for Clinical Treatment of Guangdong Pharmaceutical Association initiated and organized multidisciplinary experts to discuss and determine the consensus writing outline by using the nominal group method,forming a preliminary consensus draft;expert consultation was performed by using Delphi method,and then experts' opinions were analyzed and revised to form consensus.RESULTS & CONCLUSIONS Consensuses of Experts on the Application of Nanopore Sequencing Technology in the Detection of Pathogenic Microorganisms covers targeted sequencing,metagenomic sequencing and whole genome sequencing,and is standardized in terms of sample collection and storage,detection process,bioinformatics analysis and report interpretation;the recommendations are provided for the key issues.
作者
张述耀
侯铁英
黎小妍
钟诗龙
伍俊妍
黄彬
中国药理学会治疗药物监测研究专业基层委员会
广东省药学会临床治疗精准用药专家委员会
《纳米孔测序在病原微生物检测中的应用专家共识》编写组
ZHANG Shuyao;HOU Tieying;LI Xiaoyan;ZHONG Shilong;WU Junyan;HUANG Bin;Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society;Expert Committee of Precision Medicine for Clinical Treatment of Guangdong Pharmaceutical Association;the Writing Group of the Expert Consensuses on the Application of Nanopore Sequencing Technology in the Detection of Pathogenic Microorganisms(Clinical Precision Treatment Center,the Affiliated Guangzhou Red Cross Hospital,Jinan University,Guangzhou 510240,China;Huazhong University of Science and Technology Union Hospital(Nanshan Hospital),Guangdong Shenzhen 518101,China;Dept.of Pharmacy,the Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou 510510,China;Dept.of Pharmacy,Guangdong Provincial People’s Hospital,Guangzhou 519041,China;Dept.of Pharmacy,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Dept.of Clinical Laboratory,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;不详)
出处
《中国药房》
CAS
北大核心
2024年第14期1673-1682,共10页
China Pharmacy
基金
广东省科技创新战略专项(“大专项+任务清单”)项目(No.STKJ202209072)
广东省基础与应用基础研究基金自然科学基金-面上项目(No.2024A1515010633)
浙江省科技计划项目“尖兵”“领雁”研发攻关计划(No.2023C03068)
中国红十字基金会医学赋能公益专项(No.HSZH202200909)
毕节市“揭榜挂帅”重大专项(No.毕科合重大专项[2023]2-2号)。
关键词
第三代测序
纳米孔测序
病原微生物
危重症感染
临床检验
微生物学诊断
third-generation sequencing
nanopore sequencing
pathogenic microorganisms
critical infection
clinical laboratory tests
microbiological diagnosis